Modulation of IL-2Rα with daclizumab for treatment of multiple sclerosis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modulation of IL-2Rα with daclizumab for treatment of multiple sclerosis
Authors
Keywords
-
Journal
Nature Reviews Neurology
Volume 9, Issue 7, Pages 394-404
Publisher
Springer Nature
Online
2013-06-04
DOI
10.1038/nrneurol.2013.95
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Function for IL-7R for CD4+CD25+Foxp3+ T Regulatory Cells
- (2014) A. L. Bayer et al. JOURNAL OF IMMUNOLOGY
- Human NK Cells Kill Resting but Not Activated Microglia via NKG2D- and NKp46-Mediated Recognition
- (2014) A. Lunemann et al. JOURNAL OF IMMUNOLOGY
- Reprogramming the immune repertoire with alemtuzumab in MS
- (2013) Heinz Wiendl et al. Nature Reviews Neurology
- Teaching NeuroImages: 5-FU-induced acute leukoencephalopathy
- (2013) S. Mehta et al. NEUROLOGY
- Innate Lymphoid Cells: Emerging Insights in Development, Lineage Relationships, and Function
- (2012) Hergen Spits et al. Annual Review of Immunology
- Daclizumab Use in Patients With Pediatric Multiple Sclerosis
- (2012) Mark P. Gorman ARCHIVES OF NEUROLOGY
- IL-7 Abrogates Suppressive Activity of Human CD4+CD25+FOXP3+ Regulatory T Cells and Allows Expansion of Alloreactive and Autoreactive T Cells
- (2012) A.-K. Heninger et al. JOURNAL OF IMMUNOLOGY
- Characterization of natural killer cells in paired CSF and blood samples during neuroinflammation
- (2012) Isabell Hamann et al. JOURNAL OF NEUROIMMUNOLOGY
- Systematic review of disease-modifying therapies to assess unmet needs in multiple sclerosis: tolerability and adherence
- (2012) G Giovannoni et al. Multiple Sclerosis Journal
- CD56bright Natural Killer Cell Expansion Predicts Response to Daclizumab HYP Treatment in RRMS: Results of the SELECT Trial (S31.004)
- (2012) J. Elkins et al. NEUROLOGY
- Daclizumab Therapy for Multiple Sclerosis
- (2012) Bibiana Bielekova Neurotherapeutics
- Anti-CD25 Immunotherapy: Regulating the Regulators
- (2012) J. W. Rose Science Translational Medicine
- Inhibition of LTi Cell Development by CD25 Blockade Is Associated with Decreased Intrathecal Inflammation in Multiple Sclerosis
- (2012) J. S. A. Perry et al. Science Translational Medicine
- CD25 Blockade Depletes and Selectively Reprograms Regulatory T Cells in Concert with Immunotherapy in Cancer Patients
- (2012) A. J. Rech et al. Science Translational Medicine
- Anti-CD25 (daclizumab) monoclonal antibody therapy in relapsing–remitting multiple sclerosis
- (2011) Roland Martin CLINICAL IMMUNOLOGY
- Immune tolerance in multiple sclerosis
- (2011) Joan M. Goverman IMMUNOLOGICAL REVIEWS
- T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells
- (2011) Guoyan Cheng et al. IMMUNOLOGICAL REVIEWS
- Impaired IFN-γ production and proliferation of NK cells in Multiple Sclerosis
- (2011) Anna Lünemann et al. INTERNATIONAL IMMUNOLOGY
- IL-2 Regulates Expression of C-MAF in Human CD4 T Cells
- (2011) A. Rani et al. JOURNAL OF IMMUNOLOGY
- Unexpected Role for Granzyme K in CD56bright NK Cell-Mediated Immunoregulation of Multiple Sclerosis
- (2011) W. Jiang et al. JOURNAL OF IMMUNOLOGY
- Intermediate-affinity interleukin-2 receptor expression predicts CD56bright natural killer cell expansion after daclizumab treatment in the CHOICE study of patients with multiple sclerosis
- (2011) James P Sheridan et al. Multiple Sclerosis Journal
- Window of opportunity for daclizumab
- (2011) Kimberly S Schluns NATURE MEDICINE
- A role for interleukin-2 trans-presentation in dendritic cell–mediated T cell activation in humans, as revealed by daclizumab therapy
- (2011) Simone C Wuest et al. NATURE MEDICINE
- Intrathecal effects of daclizumab treatment of multiple sclerosis
- (2011) B. Bielekova et al. NEUROLOGY
- Inflammatory Cortical Demyelination in Early Multiple Sclerosis
- (2011) Claudia F. Lucchinetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation
- (2010) Junwei Hao et al. ANNALS OF NEUROLOGY
- T cells in multiple sclerosis and experimental autoimmune encephalomyelitis
- (2010) J. M. Fletcher et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Interleukin-2 Receptor Signaling: At the Interface between Tolerance and Immunity
- (2010) Thomas R. Malek et al. IMMUNITY
- Central nervous system (CNS)–resident natural killer cells suppress Th17 responses and CNS autoimmune pathology
- (2010) Junwei Hao et al. JOURNAL OF EXPERIMENTAL MEDICINE
- An IL-2 Paradox: Blocking CD25 on T Cells Induces IL-2-Driven Activation of CD56bright NK Cells
- (2010) J. F. Martin et al. JOURNAL OF IMMUNOLOGY
- Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta
- (2010) Daniel Wynn et al. LANCET NEUROLOGY
- The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling
- (2010) Hergen Spits et al. NATURE IMMUNOLOGY
- Lineage Relationship Analysis of RORγt+Innate Lymphoid Cells
- (2010) Shinichiro Sawa et al. SCIENCE
- Clinical Use of Anti-CD25 Antibody Daclizumab to Enhance Immune Responses to Tumor Antigen Vaccination by Targeting Regulatory T cells
- (2009) Andrew J. Rech et al. Annals of the New York Academy of Sciences
- Regulatory T Cells Are Reduced During Anti-CD25 Antibody Treatment of Multiple Sclerosis
- (2009) Unsong Oh et al. ARCHIVES OF NEUROLOGY
- Effect of Anti-CD25 Antibody Daclizumab in the Inhibition of Inflammation and Stabilization of Disease Progression in Multiple Sclerosis
- (2009) Bibiana Bielekova et al. ARCHIVES OF NEUROLOGY
- A Low Interleukin-2 Receptor Signaling Threshold Supports the Development and Homeostasis of T Regulatory Cells
- (2009) Aixin Yu et al. IMMUNITY
- CD56highCD16-CD62L- NK Cells Accumulate in Allergic Contact Dermatitis and Contribute to the Expression of Allergic Responses
- (2009) T. Carbone et al. JOURNAL OF IMMUNOLOGY
- IL2RA Genetic Heterogeneity in Multiple Sclerosis and Type 1 Diabetes Susceptibility and Soluble Interleukin-2 Receptor Production
- (2009) Lisa M. Maier et al. PLoS Genetics
- Long-term daclizumab therapy in relapsing-remitting multiple sclerosis
- (2009) Monica A. Rojas et al. Therapeutic Advances in Neurological Disorders
- Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells
- (2008) Philip L. De Jager et al. BRAIN
- Granzyme K Displays Highly Restricted Substrate Specificity That Only Partially Overlaps with Granzyme A
- (2008) Niels Bovenschen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anti-CD25 antibodies affect cytokine synthesis pattern of human dendritic cells and decrease their ability to prime allogeneic CD4+ T cells
- (2008) K. Mnasria et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Human fetal lymphoid tissue–inducer cells are interleukin 17–producing precursors to RORC+ CD127+ natural killer–like cells
- (2008) Tom Cupedo et al. NATURE IMMUNOLOGY
- Functions of natural killer cells
- (2008) Eric Vivier et al. NATURE IMMUNOLOGY
- The role of regulatory T cells in multiple sclerosis
- (2008) Alla L Zozulya et al. Nature clinical practice. Neurology
- The Biology of Interleukin-2
- (2007) Thomas R. Malek Annual Review of Immunology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now